Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
about
DNA vaccines for biodefense.Expression, purification and production of antisera against recombinant truncated VP22 proteinVP22 herpes simplex virus protein can transduce proteins into stem cells.Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses.The nuclear localization signal sequence of porcine circovirus type 2 ORF2 enhances intracellular delivery of plasmid DNA.
P2860
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax
@nl
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@ast
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@en
type
label
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax
@nl
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@ast
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@en
prefLabel
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax
@nl
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@ast
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@en
P2093
P2860
P356
P1476
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
@en
P2093
Angela E Essex-Lopresti
Freda K Stevenson
Helen C Flick-Smith
Helen S Garmory
Robert J Phillpotts
Stuart D Perkins
P2860
P2888
P356
10.1186/1479-0556-3-3
P577
2005-04-20T00:00:00Z
P5875
P6179
1020260702